https://www.selleckchem.com/pr....oducts/picrotoxin.ht
Eight patients presented with ruptured aneurysms. A mean of 1.2 devices were introduced per case. Technical failure without deployment of a WEB device occurred in 2% (2/92) of sessions. Complete aneurysm occlusion for patients with imaging follow-up was 49% (mean follow-up of 8 mo). Four aneurysms were retreated. 90% of patients had modified Rankin Scale≤2 at last clinical follow-up with no mortalities. Immediate postmarket experience with the WEB device, newly introduced at American centers, confirms safe procedural use, but long-te
Like
Comment
Share
